Eevia Health Plc: Eevia adjusts its financial calendar

Eevia Health Plc ("Eevia" or "The Company") has decided to adjust the planned time for several financial events in 2023.

 Eevia has decided for practical reasons to adjust the planned time for several financial events, as follows:

  • Interim report Q1 2023 publishing is moved from 15 MAY 2023 to 16 MAY 2023
  • The Annual General Meeting is moved from 25 MAY 2023 to 26 JUNE 2023

Hence, the revised immediate financial calendar is now as follows:

  • Interim report Q1 2023  -  16 MAY 2023
  • The Annual General Meeting  - 26 JUNE 2023
  • The Interim report Q2 2023  - 23 AUGUST 2023
  • The Interim report Q3 2023  - 22 NOVEMBER 2023

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          
Email: [email protected]                      
Telephone: +358 400 22 5967


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands use the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]